United States Biotechnology & Medical Research

Lexeo Therapeutics Inc (LXEO)

Track

Track

Lexeo Therapeutics Inc. experienced significant insider trading activity over the past ninety days, totaling fourteen transactions. Executives, including the CEO, CFO, and COO, exclusively executed sales amounting to approximately $599,637. These divestments occurred following the company's August 12th earnings report, amidst a fifteen percent stock price increase during this period.
Ticker: LXEO Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lexeo Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Tamayo Louis Edward Chief Financial Officer Officer
Transaction date
Sale
Price
423.74
Quantity 14,405 -47.6%
Value US$4,175,197
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
146.18
Quantity 3,124 -4.2%
Value US$2,322,527
2.7
Otero Jose Manuel Chief Operating Officer Officer
Transaction date
Sale
Price
443.95
Quantity 76,539 +6.7%
Value US$472,687
2.7
Otero Jose Manuel Officer Officer
Transaction date
Proposed sale
Price
4.96
Quantity 1,304
Value US$6,464
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.95
Quantity 3,345
Value US$16,562
Tamayo Louis Edward Officer Officer
Transaction date
Proposed sale
Price
4.91
Quantity 4,117
Value US$20,203
Tamayo Louis Edward Chief Financial Officer Officer
Transaction date
Sale
Price
4.49
Quantity 4,641 -4.6%
Value US$20,838
2.7
Otero Jose Manuel Chief Operating Officer Officer
Transaction date
Sale
Price
4.48
Quantity 4,666 -3.3%
Value US$20,904
Bhalla Narinder Pal Chief Medical Officer Officer
Transaction date
Sale
Price
4.42
Quantity 22,306 -21.3%
Value US$98,593
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.48
Quantity 25,947 -6.4%
Value US$116,243
2.7
Otero Jose Manuel Officer Officer
Transaction date
Proposed sale
Price
4.48
Quantity 4,666
Value US$20,919
Bhalla Narinder Pal Officer Officer
Transaction date
Proposed sale
Price
4.42
Quantity 22,306
Value US$98,684
Tamayo Louis Edward Officer Officer
Transaction date
Proposed sale
Price
4.49
Quantity 4,641
Value US$20,815
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.48
Quantity 25,947
Value US$116,185
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.06
Quantity 3,342 -1.0%
Value US$16,927
2.7
Otero Jose Manuel Chief Operating Officer Officer
Transaction date
Sale
Price
5.07
Quantity 1,302 -1.0%
Value US$6,606
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.06
Quantity 3,342
Value US$16,927
3.4
Adler Eric Officer Officer
Transaction date
Proposed sale
Price
5.06
Quantity 1,595
Value US$8,074
2.7
Otero Jose Manuel Officer Officer
Transaction date
Proposed sale
Price
5.07
Quantity 1,302
Value US$6,606
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.69
Quantity 55,000 -13.9%
Value US$313,137
3.8
Richard Nolan Townsend Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.72
Quantity 55,000
Value US$314,600
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
6.38
Quantity 10,173 -2.5%
Value US$64,924
2.7
Otero Jose Manuel Chief Operating Officer Officer
Transaction date
Sale
Price
6.40
Quantity 3,016 -2.3%
Value US$19,294
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.38
Quantity 11,374
Value US$72,585
2.7
Otero Jose Manuel Officer Officer
Transaction date
Proposed sale
Price
6.40
Quantity 3,016
Value US$19,294
3.3
See Tai Sandi Officer Officer
Transaction date
Proposed sale
Price
6.39
Quantity 3,861
Value US$24,684
3.4
Adler Eric Officer Officer
Transaction date
Proposed sale
Price
6.40
Quantity 4,867
Value US$31,135
3.4
Robertson Jenny Officer Officer
Transaction date
Proposed sale
Price
6.40
Quantity 3,736
Value US$23,897
3.3
See Tai Sandi Chief Development Officer Officer
Transaction date
Sale
Price
9.27
Quantity 386 -0.6%
Value US$3,578
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
9.27
Quantity 1,127 -0.5%
Value US$10,447
3.4
Adler Eric Chief Medical Officer Officer
Transaction date
Sale
Price
9.27
Quantity 615 -0.8%
Value US$5,701
3.4
Robertson Jenny Chief Legal Officer Officer
Transaction date
Sale
Price
9.27
Quantity 549 -0.8%
Value US$5,089
3.4
Robertson Jenny Officer Officer
Transaction date
Proposed sale
Price
9.27
Quantity 549
Value US$5,092
3.3
See Tai Sandi Officer Officer
Transaction date
Proposed sale
Price
9.27
Quantity 386
Value US$3,580
2.7
Otero Jose Manuel Officer Officer
Transaction date
Proposed sale
Price
9.27
Quantity 721
Value US$6,687
3.4
Adler Eric Officer Officer
Transaction date
Proposed sale
Price
9.27
Quantity 615
Value US$5,704
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.27
Quantity 1,127
Value US$10,452
3.4
Adler Eric Officer Officer
Transaction date
Proposed sale
Price
8.94
Quantity 3,382
Value US$30,242
2.7
Otero Jose Manuel Officer Officer
Transaction date
Proposed sale
Price
8.94
Quantity 2,115
Value US$18,913
3.4
Robertson Jenny Officer Officer
Transaction date
Proposed sale
Price
8.94
Quantity 3,526
Value US$31,530
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.94
Quantity 13,133
Value US$117,437
3.3
See Tai Sandi Officer Officer
Transaction date
Proposed sale
Price
8.94
Quantity 3,888
Value US$34,767
3.3
See Tai Sandi Chief Development Officer Officer
Transaction date
Sale
Price
9.56
Quantity 44 -0.1%
Value US$421
3.3
See Tai Sandi Chief Development Officer Officer
Transaction date
Sale
Price
8.94
Quantity 3,844 -5.5%
Value US$34,346
2.7
Otero Jose Manuel Chief Technical Officer Officer
Transaction date
Sale
Price
9.56
Quantity 24 -0.0%
Value US$229
2.7
Otero Jose Manuel Chief Technical Officer Officer
Transaction date
Sale
Price
8.94
Quantity 2,091 -3.2%
Value US$18,683
3.4
Robertson Jenny Chief Legal Officer Officer
Transaction date
Sale
Price
9.56
Quantity 40 -0.1%
Value US$382
3.4
Robertson Jenny Chief Legal Officer Officer
Transaction date
Sale
Price
8.94
Quantity 3,486 -4.8%
Value US$31,147
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
9.56
Quantity 148 -0.1%
Value US$1,415
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
8.94
Quantity 12,985 -5.1%
Value US$116,021
3.4
Adler Eric Chief Medical Officer Officer
Transaction date
Sale
Price
9.56
Quantity 38 -0.1%
Value US$363
3.4
Adler Eric Chief Medical Officer Officer
Transaction date
Sale
Price
8.94
Quantity 3,344 -4.4%
Value US$29,879
2.7
Otero Jose Manuel Chief Technical Officer Officer
Transaction date
Sale
Price
9.27
Quantity 721 -1.1%
Value US$6,684
3.4
Robertson Jenny Chief Legal Officer Officer
Transaction date
Sale
Price
4.67
Quantity 542 -0.9%
Value US$2,530
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.67
Quantity 2,735 -1.2%
Value US$12,767
2.7
Otero Jose Manuel Chief Technical Officer Officer
Transaction date
Sale
Price
4.67
Quantity 2,848 -4.5%
Value US$13,294
3.4
Adler Eric Chief Medical Officer Officer
Transaction date
Sale
Price
4.67
Quantity 608 -0.9%
Value US$2,838
3.3
See Tai Sandi Chief Development Officer Officer
Transaction date
Sale
Price
4.67
Quantity 382 -0.6%
Value US$1,783
2.7
Otero Jose Manuel Officer Officer
Transaction date
Proposed sale
Price
4.67
Quantity 2,848
Value US$13,295
3.4
Adler Eric Officer Officer
Transaction date
Proposed sale
Price
4.67
Quantity 608
Value US$2,838
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.67
Quantity 1,115
Value US$5,205
3.3
See Tai Sandi Officer Officer
Transaction date
Proposed sale
Price
4.67
Quantity 382
Value US$1,783
3.4
Robertson Jenny Officer Officer
Transaction date
Proposed sale
Price
4.67
Quantity 542
Value US$2,530
3.4
Robertson Jenny Chief Legal Officer Officer
Transaction date
Sale
Price
2.77
Quantity 521 -0.8%
Value US$1,445
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.77
Quantity 1,074 -0.5%
Value US$2,979
3.4
Adler Eric Chief Medical Officer Officer
Transaction date
Sale
Price
2.77
Quantity 585 -0.9%
Value US$1,623
3.3
See Tai Sandi Chief Development Officer Officer
Transaction date
Sale
Price
2.77
Quantity 367 -0.6%
Value US$1,018
3.8
Townsend Richard Nolan Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.77
Quantity 1,074
Value US$2,980
3.4
Robertson Jenny Officer Officer
Transaction date
Proposed sale
Price
2.77
Quantity 521
Value US$1,445
3.3
See Tai Sandi Officer Officer
Transaction date
Proposed sale
Price
2.77
Quantity 367
Value US$1,018
3.4
Adler Eric Officer Officer
Transaction date
Proposed sale
Price
2.77
Quantity 585
Value US$1,623
3.8
Townsend Richard Nolan Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.41
Quantity 4,326 -1.9%
Value US$19,091
3.4
Robertson Jenny Chief Legal Officer Officer
Transaction date
Sale
Price
4.41
Quantity 2,101 -3.5%
Value US$9,272
3.3
See Tai Sandi Chief Development Officer Officer
Transaction date
Sale
Price
4.41
Quantity 1,486 -2.7%
Value US$6,558
3.4
Adler Eric Chief Medical Officer Officer
Transaction date
Sale
Price
4.41
Quantity 2,359 -3.3%
Value US$10,410
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-18 S Sale
Tamayo Louis Edward

Chief Financial Officer

Officer
14,405 -47.6%
423.74
US$4,175,197 		14,405 -47.6% 423.74 US$4,175,197
2026-08-19 2026-08-18 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
3,124 -4.2%
146.18
US$2,322,527 		3,124 -4.2% 146.18 US$2,322,527
2026-08-19 2026-08-18 S Sale
2.7
Otero Jose Manuel

Chief Operating Officer

Officer
76,539 +6.7%
443.95
US$472,687 		76,539 +6.7% 443.95 US$472,687
2026-08-18 2026-08-18 PrS Proposed sale
2.7
Otero Jose Manuel

Officer

Officer
1,304
4.96
US$6,464 		1,304 4.96 US$6,464
2026-08-18 2026-08-18 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
3,345
4.95
US$16,562 		3,345 4.95 US$16,562
2026-08-18 2026-08-18 PrS Proposed sale
Tamayo Louis Edward

Officer

Officer
4,117
4.91
US$20,203 		4,117 4.91 US$20,203
2026-07-01 2026-07-01 S Sale
Tamayo Louis Edward

Chief Financial Officer

Officer
4,641 -4.6%
4.49
US$20,838 		4,641 -4.6% 4.49 US$20,838
2026-07-01 2026-07-01 S Sale
2.7
Otero Jose Manuel

Chief Operating Officer

Officer
4,666 -3.3%
4.48
US$20,904 		4,666 -3.3% 4.48 US$20,904
2026-07-01 2026-07-01 S Sale
Bhalla Narinder Pal

Chief Medical Officer

Officer
22,306 -21.3%
4.42
US$98,593 		22,306 -21.3% 4.42 US$98,593
2026-07-01 2026-07-01 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
25,947 -6.4%
4.48
US$116,243 		25,947 -6.4% 4.48 US$116,243
2026-07-01 2026-07-01 PrS Proposed sale
2.7
Otero Jose Manuel

Officer

Officer
4,666
4.48
US$20,919 		4,666 4.48 US$20,919
2026-07-01 2026-07-01 PrS Proposed sale
Bhalla Narinder Pal

Officer

Officer
22,306
4.42
US$98,684 		22,306 4.42 US$98,684
2026-07-01 2026-07-01 PrS Proposed sale
Tamayo Louis Edward

Officer

Officer
4,641
4.49
US$20,815 		4,641 4.49 US$20,815
2026-07-01 2026-07-01 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
25,947
4.48
US$116,185 		25,947 4.48 US$116,185
2026-05-20 2026-05-18 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
3,342 -1.0%
5.06
US$16,927 		3,342 -1.0% 5.06 US$16,927
2026-05-20 2026-05-18 S Sale
2.7
Otero Jose Manuel

Chief Operating Officer

Officer
1,302 -1.0%
5.07
US$6,606 		1,302 -1.0% 5.07 US$6,606
2026-05-18 2026-05-18 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
3,342
5.06
US$16,927 		3,342 5.06 US$16,927
2026-05-18 2026-05-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
1,595
5.06
US$8,074 		1,595 5.06 US$8,074
2026-05-18 2026-05-18 PrS Proposed sale
2.7
Otero Jose Manuel

Officer

Officer
1,302
5.07
US$6,606 		1,302 5.07 US$6,606
2026-04-07 2026-04-06 PlS Planned sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
55,000 -13.9%
5.69
US$313,137 		55,000 -13.9% 5.69 US$313,137
2026-04-06 2026-04-06 PrS Proposed sale
3.8
Richard Nolan Townsend

Director; Officer

Executive Director
55,000
5.72
US$314,600 		55,000 5.72 US$314,600
2026-02-20 2026-02-18 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
10,173 -2.5%
6.38
US$64,924 		10,173 -2.5% 6.38 US$64,924
2026-02-20 2026-02-18 S Sale
2.7
Otero Jose Manuel

Chief Operating Officer

Officer
3,016 -2.3%
6.40
US$19,294 		3,016 -2.3% 6.40 US$19,294
2026-02-18 2026-02-18 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
11,374
6.38
US$72,585 		11,374 6.38 US$72,585
2026-02-18 2026-02-18 PrS Proposed sale
2.7
Otero Jose Manuel

Officer

Officer
3,016
6.40
US$19,294 		3,016 6.40 US$19,294
2026-02-18 2026-02-18 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
3,861
6.39
US$24,684 		3,861 6.39 US$24,684
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
4,867
6.40
US$31,135 		4,867 6.40 US$31,135
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
3,736
6.40
US$23,897 		3,736 6.40 US$23,897
2025-11-20 2025-11-18 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
386 -0.6%
9.27
US$3,578 		386 -0.6% 9.27 US$3,578
2025-11-20 2025-11-18 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
1,127 -0.5%
9.27
US$10,447 		1,127 -0.5% 9.27 US$10,447
2025-11-20 2025-11-18 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
615 -0.8%
9.27
US$5,701 		615 -0.8% 9.27 US$5,701
2025-11-20 2025-11-18 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
549 -0.8%
9.27
US$5,089 		549 -0.8% 9.27 US$5,089
2025-11-18 2025-11-18 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
549
9.27
US$5,092 		549 9.27 US$5,092
2025-11-18 2025-11-18 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
386
9.27
US$3,580 		386 9.27 US$3,580
2025-11-18 2025-11-18 PrS Proposed sale
2.7
Otero Jose Manuel

Officer

Officer
721
9.27
US$6,687 		721 9.27 US$6,687
2025-11-18 2025-11-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
615
9.27
US$5,704 		615 9.27 US$5,704
2025-11-18 2025-11-18 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
1,127
9.27
US$10,452 		1,127 9.27 US$10,452
2025-10-17 2025-10-17 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
3,382
8.94
US$30,242 		3,382 8.94 US$30,242
2025-10-17 2025-10-17 PrS Proposed sale
2.7
Otero Jose Manuel

Officer

Officer
2,115
8.94
US$18,913 		2,115 8.94 US$18,913
2025-10-17 2025-10-17 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
3,526
8.94
US$31,530 		3,526 8.94 US$31,530
2025-10-17 2025-10-17 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
13,133
8.94
US$117,437 		13,133 8.94 US$117,437
2025-10-17 2025-10-17 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
3,888
8.94
US$34,767 		3,888 8.94 US$34,767
2025-10-17 2025-10-17 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
44 -0.1%
9.56
US$421 		44 -0.1% 9.56 US$421
2025-10-17 2025-10-17 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
3,844 -5.5%
8.94
US$34,346 		3,844 -5.5% 8.94 US$34,346
2025-10-17 2025-10-17 S Sale
2.7
Otero Jose Manuel

Chief Technical Officer

Officer
24 -0.0%
9.56
US$229 		24 -0.0% 9.56 US$229
2025-10-17 2025-10-17 S Sale
2.7
Otero Jose Manuel

Chief Technical Officer

Officer
2,091 -3.2%
8.94
US$18,683 		2,091 -3.2% 8.94 US$18,683
2025-10-17 2025-10-17 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
40 -0.1%
9.56
US$382 		40 -0.1% 9.56 US$382
2025-10-17 2025-10-17 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
3,486 -4.8%
8.94
US$31,147 		3,486 -4.8% 8.94 US$31,147
2025-10-17 2025-10-17 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
148 -0.1%
9.56
US$1,415 		148 -0.1% 9.56 US$1,415
2025-10-17 2025-10-17 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
12,985 -5.1%
8.94
US$116,021 		12,985 -5.1% 8.94 US$116,021
2025-10-17 2025-10-17 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
38 -0.1%
9.56
US$363 		38 -0.1% 9.56 US$363
2025-10-17 2025-10-17 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
3,344 -4.4%
8.94
US$29,879 		3,344 -4.4% 8.94 US$29,879
2025-11-20 2025-08-18 S Sale
2.7
Otero Jose Manuel

Chief Technical Officer

Officer
721 -1.1%
9.27
US$6,684 		721 -1.1% 9.27 US$6,684
2025-08-20 2025-08-18 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
542 -0.9%
4.67
US$2,530 		542 -0.9% 4.67 US$2,530
2025-08-20 2025-08-18 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
2,735 -1.2%
4.67
US$12,767 		2,735 -1.2% 4.67 US$12,767
2025-08-20 2025-08-18 S Sale
2.7
Otero Jose Manuel

Chief Technical Officer

Officer
2,848 -4.5%
4.67
US$13,294 		2,848 -4.5% 4.67 US$13,294
2025-08-20 2025-08-18 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
608 -0.9%
4.67
US$2,838 		608 -0.9% 4.67 US$2,838
2025-08-20 2025-08-18 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
382 -0.6%
4.67
US$1,783 		382 -0.6% 4.67 US$1,783
2025-08-18 2025-08-18 PrS Proposed sale
2.7
Otero Jose Manuel

Officer

Officer
2,848
4.67
US$13,295 		2,848 4.67 US$13,295
2025-08-18 2025-08-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
608
4.67
US$2,838 		608 4.67 US$2,838
2025-08-18 2025-08-18 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
1,115
4.67
US$5,205 		1,115 4.67 US$5,205
2025-08-18 2025-08-18 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
382
4.67
US$1,783 		382 4.67 US$1,783
2025-08-18 2025-08-18 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
542
4.67
US$2,530 		542 4.67 US$2,530
2025-05-20 2025-05-16 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
521 -0.8%
2.77
US$1,445 		521 -0.8% 2.77 US$1,445
2025-05-20 2025-05-16 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
1,074 -0.5%
2.77
US$2,979 		1,074 -0.5% 2.77 US$2,979
2025-05-20 2025-05-16 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
585 -0.9%
2.77
US$1,623 		585 -0.9% 2.77 US$1,623
2025-05-20 2025-05-16 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
367 -0.6%
2.77
US$1,018 		367 -0.6% 2.77 US$1,018
2025-05-16 2025-05-16 PrS Proposed sale
3.8
Townsend Richard Nolan

Officer; Director

Executive Director
1,074
2.77
US$2,980 		1,074 2.77 US$2,980
2025-05-16 2025-05-16 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
521
2.77
US$1,445 		521 2.77 US$1,445
2025-05-16 2025-05-16 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
367
2.77
US$1,018 		367 2.77 US$1,018
2025-05-16 2025-05-16 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
585
2.77
US$1,623 		585 2.77 US$1,623
2025-02-21 2025-02-19 S Sale
3.8
Townsend Richard Nolan

Chief Executive Officer

Executive Director
4,326 -1.9%
4.41
US$19,091 		4,326 -1.9% 4.41 US$19,091
2025-02-21 2025-02-19 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
2,101 -3.5%
4.41
US$9,272 		2,101 -3.5% 4.41 US$9,272
2025-02-21 2025-02-19 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
1,486 -2.7%
4.41
US$6,558 		1,486 -2.7% 4.41 US$6,558
2025-02-21 2025-02-19 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
2,359 -3.3%
4.41
US$10,410 		2,359 -3.3% 4.41 US$10,410
Explore more

More insider trading research around Lexeo Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America